Bone defect healing with an osteogenic protein‐1 device combined with carboxymethylcellulose
- 20 July 2005
- journal article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 75B (1), 137-145
- https://doi.org/10.1002/jbm.b.30271
Abstract
One consideration for the practical use and application of osteogenic proteins is an effective method of delivery. This study evaluated a putty‐type collagen carrier with recombinant human osteogenic protein‐1 (rhOP‐1) ability to heal canine critical sized (2.5 cm) ulna segmental defects compared to rhOP‐1 with a particulate collagen carrier (OP device). The addition of carboxymethylcellulose (CMC) to the particulate collagen carrier (OPCMC device) to form the putty consistency was evaluated in two doses (3.5 and 1.75 mg rhOP‐1/g carrier). The CMC greatly improved the intraoperative handling and site containment of the device. For the one‐half dose and full‐dose sites there were no statistically significant differences in the radiographic grading of defect healing when treated with the particulate OP‐1 device and the device with CMC added. However, there was a dose effect with greater and earlier new bone formation observed with increased rhOP‐1. Mechanically, there were no differences between particulate and putty formulations, although again, a significant effect was observed for treatment dose with the full‐dose OPCMC device restoring 94% of the strength of the intact ulna compared to only 65% for the identical one‐half dose implant. Regardless of rhOP‐1 dose, the quality of union grading and total histologic score appearance were improved with the addition of CMC, although differences in histologic scoring were not statistically significant. Overall, the radiographic, mechanical, and histologic bone‐healing characteristics with the one‐half dose OPCMC device were similar to sites treated with the full‐dose OP device. The observed improvement in healing may allow for lesser amounts of the device or a device with less rhOP‐1 to be used. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2005Keywords
This publication has 26 references indexed in Scilit:
- The Evaluation of Lyophilized Polymer Matrices for Administering Recombinant Human Bone Morphogenetic Protein-2Pharmaceutical Development and Technology, 1996
- In Vivo Evaluation of Recombinant Human Osteogenic Protein (rhOP-1) Implants As a Bone Graft Substitute for Spinal FusionsSpine, 1994
- Bone graft and bone graft substitutes: A review of current technology and applicationsJournal of Applied Biomaterials, 1991
- Bone induction by composite of bioerodible polyorthoester and demineralized bone matrix in ratsActa Orthopaedica, 1991
- Periosteal Bone Formation Elicited by Partially Purified Bone Morphogenetic ProteinPublished by Ovid Technologies (Wolters Kluwer Health) ,1989
- Fibroblast growth factor stimulates bone formation Bone induction studied in ratsActa Orthopaedica, 1989
- Novel Regulators of Bone Formation: Molecular Clones and ActivitiesScience, 1988
- Bone Cell Differentiation and Growth FactorsScience, 1983
- Chondrogenesis in Tissue Cultures of Muscle Under the Influence of a Diffusible Component of Bone MatrixExperimental Biology and Medicine, 1977
- Bone: Formation by AutoinductionScience, 1965